| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 3584 |
| 1 | DOCOSANOL | 2458 |
| 2 | GLYCERIN, LIDOCAINE | 2423 |
| 3 | METHOTREXATE SODIUM | 1692 |
| 4 | METHOTREXATE | 1494 |
| 5 | PREDNISONE | 1333 |
| 6 | ADALIMUMAB | 1123 |
| 7 | ETANERCEPT | 992 |
| 8 | OCRELIZUMAB | 934 |
| 9 | ACETAMINOPHEN | 837 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GLYCERIN, LIDOCAINE | 2423 | 0.1738 |
| 1 | DOCOSANOL | 2458 | 0.1684 |
| 2 | INFLIXIMAB-DYYB | 172 | 0.0499 |
| 3 | PENCICLOVIR | 16 | 0.0442 |
| 4 | TALIMOGENE LAHERPAREPVEC | 47 | 0.0296 |
| 5 | ERGOCALCIFEROL | 742 | 0.0250 |
| 6 | MEXILETINE HYDROCHLORIDE | 10 | 0.0238 |
| 7 | GOLIMUMAB | 252 | 0.0200 |
| 8 | ESTRADIOL VALERATE | 14 | 0.0180 |
| 9 | PSYLLIUM HUSK | 23 | 0.0170 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 3584 |
| 1 | Corticosteroid [EPC] | 2569 |
| 2 | Non-Standardized Chemical Allergen [EPC] | 2540 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 2056 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1833 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 1559 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 1491 |
| 7 | Vitamin C [EPC] | 979 |
| 8 | Benzodiazepine [EPC] | 831 |
| 9 | Proton Pump Inhibitor [EPC] | 775 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 47 | 0.0683 |
| 1 | Non-Standardized Chemical Allergen [EPC] | 2540 | 0.0328 |
| 2 | Provitamin D2 Compound [EPC] | 742 | 0.0249 |
| 3 | Partial Opioid Agonist/Antagonist [EPC] | 1 | 0.0208 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 29 | 0.0140 |
| 5 | Interleukin-17A Antagonist [EPC] | 483 | 0.0130 |
| 6 | Blood Viscosity Reducer [EPC] | 56 | 0.0129 |
| 7 | Tyrosine Kinase 2 Inhibitor [EPC] | 35 | 0.0118 |
| 8 | Asparagine-specific Enzyme [EPC] | 130 | 0.0096 |
| 9 | Adrenocorticotropic Hormone [EPC] | 7 | 0.0078 |